OSE Immunotherapeutics S.A.

OSE.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€16,745€18,672€25,620€33,579
Short-Term Investments€0€0€0€0
Receivables€4,138€1,805€8,128€1,594
Inventory€0€0€0€0
Other Curr. Assets€49,049€10,001€3,452€9,033
Total Curr. Assets€69,932€30,478€37,200€44,206
Property Plant & Equip (Net)€3,425€4,070€4,979€5,439
Goodwill€0€0€0€0
Intangibles€44,010€46,401€48,784€51,122
Long-Term Investments€6,400€756€524€581
Tax Assets€191€195€183€173
Other NC Assets€1€154€0€0
Total NC Assets€54,027€51,576€54,470€57,315
Other Assets€0€0€0€0
Total Assets€123,959€82,054€91,670€101,521
Liabilities
Payables€3,397€6,360€4,563€2,955
Short-Term Debt€8,389€7,261€3,976€2,367
Tax Payable€0€20€21€14
Deferred Revenue€0€347€812€1,046
Other Curr. Liab.€4,369€4,811€6,896€10,380
Total Curr. Liab.€20,221€18,799€16,268€16,762
LT Debt€38,338€38,540€40,817€34,767
Deferred Rev, NC€100€1€3,586€3,965
Deferred Tax Liab, NC€1,074€1,311€1,514€1,748
Other NC Liab.€415€429€524€709
Total NC Liab.€39,927€40,280€42,855€37,224
Other Liabilities€0€0€0€0
Cap. Leases€3,274€3,890€4,469€4,721
Total Liabilities€60,148€59,079€59,123€53,986
Equity
Pref Stock€0€155€0€0
Common Stock€4,388€4,330€3,705€3,705
Retained Earnings-€17,871-€23,003-€35,889-€21,110
AOCI-€293-€309-€220-€150
Other Equity€77,295€41,648€65,062€65,445
Total Equity€63,811€22,821€32,547€47,890
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€123,959€82,054€91,670€101,521
Net Debt€29,982€27,129€19,173€3,555
OSE Immunotherapeutics S.A. (OSE.PA) Financial Statements & Key Stats | AlphaPilot